GH Research (GHRS) Income towards Parent Company (2020 - 2025)

GH Research's (GHRS) quarterly Income towards Parent Company came in at -$14.1 million in Q4 2025, down 60.61% year-on-year from -$35.9 million in Q4 2024, and down 0.83% quarter-over-quarter from -$14.0 million in Q3 2025.

GH Research (GHRS) Income towards Parent Company (2020 - 2025) Analysis & Trends

GH Research's Income towards Parent Company history runs 6 years deep, the most recent figure standing at -$14.1 million for Q4 2025.

  • On a quarterly basis, Income towards Parent Company fell 60.61% year-over-year to -$14.1 million in Q4 2025; TTM through Dec 2025 was -$48.3 million, a 23.86% decrease from a year earlier, with the FY2025 full-year figure at -$48.3 million, down 23.86% from the prior year.
  • Income towards Parent Company retreated to -$14.1 million in Q4 2025 per GHRS's latest filing, from -$14.0 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $334000.0 in Q2 2022 and bottomed at -$16.6 million in Q4 2022.
  • The 5-year median for Income towards Parent Company is -$8.3 million (2023), against an average of -$7.7 million.
  • Across the five-year window, Income towards Parent Company tumbled 2961.67% in 2021 and surged 115.72% in 2022, its largest moves.
  • Year by year, Income towards Parent Company stood at -$4.1 million in 2021, then sank by 305.43% to -$16.6 million in 2022, then surged by 32.04% to -$11.3 million in 2023, then climbed by 21.91% to -$8.8 million in 2024, then tumbled by 60.61% to -$14.1 million in 2025.
  • Per Business Quant, the three latest GHRS Income towards Parent Company figures stand at -$14.1 million (Q4 2025), -$14.0 million (Q3 2025), and -$9.3 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 GH Research 1.65 Bn 1.65 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -14.14 Mn
Sep 30, 2025 -14.02 Mn
Jun 30, 2025 -9.29 Mn
Mar 31, 2025 -10.81 Mn
Dec 31, 2024 -8.80 Mn
Sep 30, 2024 -12.11 Mn
Jun 30, 2024 -10.38 Mn
Mar 31, 2024 -7.67 Mn
Dec 31, 2023 -11.27 Mn
Sep 30, 2023 -5.65 Mn
Jun 30, 2023 -7.73 Mn
Mar 31, 2023 -10.94 Mn
Dec 31, 2022 -16.59 Mn
Sep 30, 2022 -441,000.00
Jun 30, 2022 334,000.00
Mar 31, 2022 -5.76 Mn
Dec 31, 2021 -4.09 Mn
Sep 30, 2021 -1.84 Mn
Jun 30, 2021 -2.13 Mn
Mar 31, 2021 -1.15 Mn